Billy Wynne

ARPA-H Launches AI-Enabled “IGoR” Program to Transform Biomedical Research; Solution Summaries Due June 25 and Full Proposals Due August 6

By Billy Wynne / May 7, 2026

The Advanced Research Projects Agency for Health (ARPA-H), through the Department of Health and Human Services (HHS), announced the Intelligent Generator of Research (IGoR), a…

Read More

Department Delays Compliance Deadlines for Disability Accessibility Requirements for Websites and Mobile Applications; Signals Future Revisions to Disability Nondiscrimination Framework

By Billy Wynne / May 7, 2026

The Department of Health and Human Services’ (HHS) Office for Civil Rights (OCR) released an interim final rule (IFR) entitled “Extension of Compliance Dates for…

Read More

Sen. Cassidy Holds Field Hearing in Louisiana Examining Health Care Affordability Ahead of Senate Primary

By Billy Wynne / May 6, 2026

Yesterday, Senate Health, Education, Labor, and Pensions (HELP) Committee Chair Bill Cassidy (R-LA) convened a field hearing in Baton Rouge, LA, to examine drivers of…

Read More

Administration Releases Analysis of Savings from Most-Favored-Nation Drug Pricing Policy; Estimates $529 Billion in Savings Over 10 Years

By Billy Wynne / May 5, 2026

The White House released an analysis of the Administration’s Most-Favored-Nation (MFN) drug pricing policy, prepared by administration officials for the Council of Economic Advisers. The…

Read More

LEAD Model Clarifications from Alignment and Financial Methodology Office Hour

By Billy Wynne / May 5, 2026

Today, the Center for Medicare & Medicaid Innovation (CMMI/Innovation Center) held an office hour on the LEAD (Long-term Enhanced ACO Design) Model, providing additional detail on…

Read More

House Passes Farm Bill Reauthorization

By Billy Wynne / May 1, 2026

The House passed the Farm, Food, and National Security Act for Farm Bill reauthorization (fact sheet; text) by a vote of 224-200. In addition to agricultural programs,…

Read More

Agency Proposes to Exclude GLP-1 Therapies from 503B Bulks List; Comments due June 29

By Billy Wynne / May 1, 2026

The Food and Drug Administration (FDA) issued a notice proposing to exclude three widely used GLP-1 therapies – semaglutide, tirzepatide, and liraglutide – from the…

Read More

Committee Passes USDA and FDA Funding Bill; Democrats Highlight WIC Cuts While Republicans Emphasize Fiscal Responsibility

By Billy Wynne / April 30, 2026

The Appropriations Committee passed the fiscal year (FY) 2027 funding bill for Agriculture, Rural Development, Food and Drug Administration, and Related Agencies (text; report; summary). The bill appropriates funding for…

Read More

Agency Further Extends GENEROUS Model Application Deadlines for Manufacturers and States

By Billy Wynne / April 29, 2026

The Centers for Medicare and Medicaid Services (CMS) announced additional deadline extensions for the GENEROUS (GENErating cost Reductions fOr U.S. Medicaid) Model, citing overwhelming interest…

Read More

Committee Convenes Hospital CEOs to Examine Drivers of Rising Health Care Costs

By Billy Wynne / April 29, 2026

The House Ways & Means Committee (W&M) convened hospital system CEOs as part of a broader Republican oversight series aimed at examining and reducing health…

Read More